Assertio Holdings Inc
NASDAQ:ASRT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
Tate & Lyle PLC
LSE:TATE
|
UK |
|
Prima Alloy Steel Universal Tbk PT
IDX:PRAS
|
ID |
|
LHN Ltd
SGX:41O
|
SG |
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
Tourmaline Bio Inc
NASDAQ:TRML
|
US |
|
Oceania Healthcare Ltd
ASX:OCA
|
NZ |
Wall St Price Targets
ASRT Price Targets Summary
Assertio Holdings Inc
According to Wall Street analysts, the average 1-year price target for ASRT is 24.34 USD with a low forecast of 22.02 USD and a high forecast of 29.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASRT's stock price target?
Price Target
24.34
USD
According to Wall Street analysts, the average 1-year price target for ASRT is 24.34 USD with a low forecast of 22.02 USD and a high forecast of 29.4 USD.
What is the Revenue forecast for Assertio Holdings Inc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 6 years is 2%.